Top Markets
#1 0G 0G +39.62%
#2 Full Moon Full Moon +30.02%
#3 VVS Finance VVS Finance +29.65%
#4 Axelar Axelar +27.70%
#5 Nockchain Nockchain +21.57%
#6 Fake World Assets Fake World Assets +20.93%
#7 Wrapped CRO Wrapped CRO +20.60%
#8 StonkBroker StonkBroker +20.53%
#9 Notcoin Notcoin +18.38%
#10 Zora Zora +18.18%
Coin of the day
0G 0G
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
Classifica tra le azioni #13175
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Prezzo delle azioni
$8.46
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$514.33M
Variazione (1 giorno)
-2.08%
Variazione (1 anno)
128.03%
Paese
US
Scambia Kyverna Therapeutics, Inc. (KYTX)

Categoria

Healthcare
Il prezzo KYTX con la capitalizzazione del mercato della B
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.
KYTX
$8.46
Capitalizzazione di mercato di Kyverna Therapeutics, Inc.(KYTX)
Capitalizzazione di mercato: $514.33M
A partire dal August 2026, Kyverna Therapeutics, Inc. ha una capitalizzazione di mercato pari a $514.33M. Questo rende Kyverna Therapeutics, Inc. la 13175th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Kyverna Therapeutics, Inc. dal 2024 al 2026
KYTX in paragone con la classifica dei più popolari stocks
Il prezzo per KYTX Attivo B Capitalizzazione del mercato a B Risultati
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.
$86,583.59 $514.33M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.264T +1,023,346.70%
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.
$77,329.71 $514.33M
Apple Inc. Apple Inc.
AAPL
$4.701T +913,962.73%
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.
$68,708.99 $514.33M
Alphabet Inc. Alphabet Inc.
GOOG
$4.177T +812,063.03%
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.
$62,791.15 $514.33M
Microsoft Corporation Microsoft Corporation
MSFT
$3.817T +742,112.15%
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.
$47,147.41 $514.33M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.866T +557,198.01%